SCHEMBL17278704

SCHEMBL17278704

c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2nc(-c3ccc(N4c5ccccc5Oc5ccccc54)cc3)nc(-c3ccc(N4c5ccccc5Sc5ccccc54)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 1/20 0.46
▸ MAOA P21397 1/20 0.35
▸ P2RX4 Q99571 3/20 0.33
▸ BCHE P06276 5/20 0.33
▸ ACHE P22303 2/20 0.33
▸ NOX1 Q9Y5S8 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17278701 1.00 HDAC6 (0.46) HDAC6MAOAP2RX4BCHEACHE
SCHEMBL17278670 0.97 HDAC6 (0.44) HDAC6MAOAP2RX4BCHEACHE
SCHEMBL17278672 0.96 HDAC6 (0.43) HDAC6MAOAP2RX4BCHEACHE
SCHEMBL17278520 0.91 HDAC6 (0.40) HDAC6P2RX4BCHEACHEMAPT
SCHEMBL17279248 0.90 HDAC6 (0.39) HDAC6LMNAMAPT
SCHEMBL17278708 0.90 HDAC6 (0.39) HDAC6MAOA
SCHEMBL16271056 0.89 P2RX4 (0.39) P2RX4MAPTL3MBTL1SMN1; SMN2
SCHEMBL16449658 0.89 HDAC6 (0.54) HDAC6MAOABCHEACHENOX1
SCHEMBL31059182 0.89 P2RX4 (0.39) P2RX4MAPTL3MBTL1SMN1; SMN2
SCHEMBL17278506 0.88 HDAC6 (0.38) HDAC6BCHENOX1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11730052-B2 Light-emitting device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-15 — — US disclosed
US-11730052-B2 Light-emitting device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-15 — — US disclosed
US-20190109285-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2019-04-11 — — US disclosed
US-10186665-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2019-01-22 — — US disclosed
US-9882144-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2018-01-30 — — US disclosed
US-9882144-B2 Organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2018-01-30 — — US disclosed
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 — — US disclosed
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2016-07-07 — — US disclosed
US-20160028025-A1 LIGHT-EMITTING DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-28 — — US disclosed
US-20160028025-A1 LIGHT-EMITTING DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-28 — — US disclosed
US-20150340623-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-11-26 — — US disclosed
US-20150340623-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190109285-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, TRPA1, EML4 HDAC6 3505/4885MAOA 1482/4885P2RX4 1633/4885
US-11730052-B2 Light-emitting device GRK7, GRK1, CTNND1 HDAC6 4858/4885MAOA 2598/4885P2RX4 4281/4885
US-10186665-B2 Organic electroluminescent element TCF4, TRPA1, EML4 HDAC6 3505/4885MAOA 1482/4885P2RX4 1633/4885
US-20160197287-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AOC2, AZI2, RER1 HDAC6 3806/4885MAOA 641/4885P2RX4 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback